Personalized cancer vaccine is associated with promising outcomes for patients with AML
A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical ...
Dec 7, 2016
0
184